Favorable response to mammalian target of rapamycin inhibition in a young patient with unresectable fibrolamellar carcinoma of the liver.
Ruben BillMatteo MontaniBenedikt BlumJean-François DufourRobert EscherMichael BühlmannPublished in: Hepatology (Baltimore, Md.) (2018)